These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18429112)

  • 1. Detection and analysis of proteins modified by O-linked N-acetylglucosamine.
    Zachara NE; Cole RN; Hart GW; Gao Y
    Curr Protoc Protein Sci; 2001 Nov; Chapter 12():Unit 12.8. PubMed ID: 18429112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of O-GlcNAc sites on proteins.
    Whelan SA; Hart GW
    Methods Enzymol; 2006; 415():113-33. PubMed ID: 17116471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and analysis of (O-linked beta-N-acetylglucosamine)-modified proteins.
    Zachara NE
    Methods Mol Biol; 2009; 464():227-54. PubMed ID: 18951188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and Analysis of Proteins Modified by O-Linked N-Acetylglucosamine.
    Fahie K; Narayanan B; Zahra F; Reeves R; Fernandes SM; Hart GW; Zachara NE
    Curr Protoc; 2021 May; 1(5):e129. PubMed ID: 34004049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global identification of O-GlcNAc-modified proteins.
    Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
    Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
    Zachara NE; Cheung WD; Hart GW
    Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WGA-based lectin affinity gel electrophoresis: A novel method for the detection of O-GlcNAc-modified proteins.
    Kubota Y; Fujioka K; Takekawa M
    PLoS One; 2017; 12(7):e0180714. PubMed ID: 28686627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.
    Vosseller K; Trinidad JC; Chalkley RJ; Specht CG; Thalhammer A; Lynn AJ; Snedecor JO; Guan S; Medzihradszky KF; Maltby DA; Schoepfer R; Burlingame AL
    Mol Cell Proteomics; 2006 May; 5(5):923-34. PubMed ID: 16452088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and analysis of proteins modified by O-linked N-acetylglucosamine.
    Zachara NE; Vosseller K; Hart GW
    Curr Protoc Protein Sci; 2011 Nov; Chapter 12():12.8.1-12.8.33. PubMed ID: 22045558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting the "O-GlcNAc-ome"; detection, purification, and analysis of O-GlcNAc modified proteins.
    Zachara NE
    Methods Mol Biol; 2009; 534():251-79. PubMed ID: 19277546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of new O-GlcNAc modified proteins using a click-chemistry-based tagging.
    Gurcel C; Vercoutter-Edouart AS; Fonbonne C; Mortuaire M; Salvador A; Michalski JC; Lemoine J
    Anal Bioanal Chem; 2008 Apr; 390(8):2089-97. PubMed ID: 18369606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of O-linked β-D-N-acetylglucosamine-modified proteins from Arabidopsis.
    Xu SL; Chalkley RJ; Wang ZY; Burlingame AL
    Methods Mol Biol; 2012; 876():33-45. PubMed ID: 22576084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant fungal lectin as a new tool to investigate O-GlcNAcylation processes.
    Machon O; Baldini SF; Ribeiro JP; Steenackers A; Varrot A; Lefebvre T; Imberty A
    Glycobiology; 2017 Jan; 27(2):123-128. PubMed ID: 27798069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and analysis of proteins modified by O-linked N-acetylglucosamine.
    Zachara NE; Hart GW; Cole RN; Gao Y
    Curr Protoc Mol Biol; 2002 Feb; Chapter 17():Unit 17.6. PubMed ID: 18265305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tagging-via-substrate strategy for probing O-GlcNAc modified proteins.
    Sprung R; Nandi A; Chen Y; Kim SC; Barma D; Falck JR; Zhao Y
    J Proteome Res; 2005; 4(3):950-7. PubMed ID: 15952742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
    Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased N-acetyl-beta-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins.
    Slawson C; Pidala J; Potter R
    Biochim Biophys Acta; 2001 Sep; 1537(2):147-57. PubMed ID: 11566258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
    Dauphinee SM; Ma M; Too CK
    J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.
    Ogawa M; Sawaguchi S; Kamemura K; Okajima T
    Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.